SpringWorks Therapeutics Announces Closing Of Initial Public Offering and Exercise in Full of the Underwriter’s Option to Purchase Additional Shares

    NEXT STORY
    iBio’s Collaboration with South Africa’s AzarGen Biotechnologies Advances to Next Stage
    PREV STORY
    Translate Bio Announces Proposed Public Offering of Common Stock
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Idera Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Provides Corporate Update

    EXTON, Pa. and CAMBRIDGE, Mass., March 07, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. ...

    author_avatar
    NASDAQ Market News

    American Health Council Recognizes Anikar Chhabra, MD, MS as “America’s Best Doctor”

    NEW YORK, Nov. 17, 2017 (GLOBE NEWSWIRE) -- The American Health Council names Anikar ...

    author_avatar
    NASDAQ Market News

    Vical Reports Phase 2 Trial of HSV-2 Therapeutic Vaccine Did Not Meet Primary Endpoint

    Company to focus on advancing VL-2397 and other pipeline opportunitiesSAN DIEGO, June 11, 2018 ...

    author_avatar
    NASDAQ Market News